Oskar Clewe, Ph.D.

Director, MIDD Consultant

Portrait-of-Oskar-Clewe_Pharmetheus-1

Bio

  • Joined Pharmetheus in 2024, actively working in client projects
  • Expertise includes pharmacometrics and model informed drug development (MIDD) in therapeutic areas such as cardiovascular, metabolic and hepatology
  • Previously, he worked as Clinical Pharmacometrician at Astra Zeneca, Sweden, where he developed and carried out pharmacometric and MIDD approaches by expert PKPD data integration, analysis, interpretation, and reporting of M&S results, as Pharmacometrician at Boehringer Ingelheim, Germany, and as Researcher at Uppsala University, Sweden 
  • M.Sc. in Pharmacy (2011) from University of Gothenburg, Sweden, and Ph.D. in Pharmaceutical Sciences (2016) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

The use of full random effect models (FREM) in model informed precision dosing (MIPD) for a priori dose predictions